Immune‐mediated drug‐induced liver injury secondary to Omeprazole: A case report

Omeprazole is a rare cause of DILI with autoimmune hepatitis features and should be considered when seeing patients with acute liver injury. The causative drug should be promptly identified and discontinued to avoid any permanent liver damage.

Detalles Bibliográficos
Autores principales: Seife Hassen, Sara, Ata, Fateen, Bint I Bilal, Ammara, Salih Ali, Mohamed, Petkar, Mahir, Awad Elzouki, Abdelnaser Y., Zahid, Muhammad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7752310/
https://www.ncbi.nlm.nih.gov/pubmed/33363945
http://dx.doi.org/10.1002/ccr3.3421
Descripción
Sumario:Omeprazole is a rare cause of DILI with autoimmune hepatitis features and should be considered when seeing patients with acute liver injury. The causative drug should be promptly identified and discontinued to avoid any permanent liver damage.

Ejemplares similares